A phase IB clinical trial of 15Â Gy HDR brachytherapy followed by hypofractionated/SBRT in the management of intermediate-risk prostate cancer
Den, Robert B., Greenspan, Jacob, Doyle, Laura A., Harrison, Amy S., Peng, Cheng, Williams, Noelle L., Lallas, Costas D., Trabulsi, Edouard J., Gomella, Leonard G., Hurwitz, Mark D., Leiby, Benjamin,Volume:
19
Journal:
Brachytherapy
DOI:
10.1016/j.brachy.2020.02.008
Date:
May, 2020
File:
PDF, 359 KB
2020